Venlafaxine ER Blocks the Norepinephrine Transporter in the Brain of Patients with Major Depressive Disorder: a PET Study Using [18F]FMeNER-D2.

MLA

Arakawa, Ryosuke, et al. “Venlafaxine ER Blocks the Norepinephrine Transporter in the Brain of Patients with Major Depressive Disorder: A PET Study Using [18F]FMeNER-D2.” International Journal of Neuropsychopharmacology, vol. 22, no. 4, Apr. 2019, pp. 278–85. EBSCOhost, https://doi.org/10.1093/ijnp/pyz003.

APA

Arakawa, R., Stenkrona, P., Takano, A., Svensson, J., Andersson, M., Nag, S., Asami, Y., Hirano, Y., Halldin, C., & Lundberg, J. (2019). Venlafaxine ER Blocks the Norepinephrine Transporter in the Brain of Patients with Major Depressive Disorder: a PET Study Using [18F]FMeNER-D2. International Journal of Neuropsychopharmacology, 22(4), 278–285. https://doi.org/10.1093/ijnp/pyz003

Chicago

Arakawa, Ryosuke, Per Stenkrona, Akihiro Takano, Jonas Svensson, Max Andersson, Sangram Nag, Yuko Asami, Yoko Hirano, Christer Halldin, and Johan Lundberg. 2019. “Venlafaxine ER Blocks the Norepinephrine Transporter in the Brain of Patients with Major Depressive Disorder: A PET Study Using [18F]FMeNER-D2.” International Journal of Neuropsychopharmacology 22 (4): 278–85. doi:10.1093/ijnp/pyz003.